Men with certain types of heart disease who have been diagnosed with prostate cancer should think very carefully before agreeing to hormone therapy designed to shrink the tumor. A new study published in the Journal of the American Medical Association found that men who take hormones to lower their testosterone levels and have brachytherapy (a procedure where radioactive seeds are placed next to cancer cells) were at a much higher risk of dying from heart disease.
The mortality rate for the 256 participants in the study who had heart disease and also underwent hormone therapy was 26.3 percent. The rate for men who skipped the hormone therapy was 11.2 percent.
Men who are diagnosed with prostate cancer have options available to them other than hormone therapy. They can consider undergoing external beam radiation or a prostatectomy instead.